1-A POS LIVE 0001589150 XXXXXXXX 024-12505 true Regen Biopharma, Inc. NV 2012 0001589150 2834 45-5192997 1 0 4700 Spring Street St 304 La Mesa CA 91942 619-722-5505 David R Koos Other 716.00 17733.00 94873.00 0.00 177611.00 5371640.00 0.00 5371640.00 -5194029.00 177611.00 236560.00 654749.00 28998.00 -867252.00 -0.21 -0.21 None Common Stock 5258235 75886M300 OTC Pink A 10123771 75886M409 OTC Pink M 29338 000000000 None AA 34 000000000 None NC 15007 000000000 None Convertible Notes 250000 000000000 None Convertible Notes 499880 000000000 None Convertible Notes 48750 000000000 None Promissory Notes 15000 000000000 None Promissory Notes 25000 000000000 None true true Tier1 Unaudited Equity (common or preferred stock) Y N Y Y N N 16666667 21554705 0.0300 0.03 0.00 0.00 0.00 0.03 true CO DE NY Regen Biopharma Inc. Common 1619919 0 $205,456 Market Value of stock as of date of issuance. 500,000 shares of stock issued as Commitment Fee for Financing and 249,915 shares of common stock as consideration for nonemeployee services, 500,000 shares issued November 4, 2024 in settlement of $20,000 of principal indebtedness owed by the Company, $33,307 Market Value as of date of issuance 370,084 common shares issued as consideration for nonemeployee services Regen Biopharma Inc. Series A Preferred 20068 0 $13,044. Market Value of stock as of date of issuance. Stock issued as consideration for consulting services Regen Biopharma Inc. Promissory Notes 390000 0 $340,000 Cash actually received less Original Issue Discount Section 4(2) of the Securities Act of 1933. Transaction by the issuer not involving a public offering.